Dr Glyn Stacey - UK Stem Cell Bank Director
Areas of interest
Suitability of cell lines for manufacture of vaccines and biotherapeutics.
Phenotypic and genotypic stability of pluripotent stem cells in vitro
Representation on external committees
PAS157 (raw materials for cell therapy) Steering Group, 2014
UK standing advisory committee for the Safety of Blood Tissues and Organs (SaBTO), co-opted for 2014
Observer on the HFEA Scientific and Clinical Advances Advisory Committee, 2014
Department of Health Regenerative Medicine Expert Group, 2014-
Stem Cells for Safer Medicine, Scientific Advisory Board, 2007-2011 (chair) 2011-present (member).
British Standards Committee, CH/194/1, British Standards Institute, 2007-present.
Coordinator and rapporteur, International Stem Cell Banking Initiative, 2007-present.
Rapporteur, WHO Cell Substrates Study Group, May 2006-present.
UK RMP Safety Hub, Chair of SAB, 2014